Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity... Read more.
Cyberlux Corporation Reports FY 2024 Results with $48.4M in Revenue, 137% Growth Over 2023 and Strong Year-End Positioning
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–$CYBL #AnnualReport–Cyberlux Corporation (OTC: CYBL), a leading provider of advanced defense technologies,... Read more.
Karman Space & Defense Extends 10K Filing Date as Audit Support for February IPO Lengthens Full Year Audit Timeline; Affirms Strong 2024 Financial Performance and Schedules Full Fiscal Year 2024 Earnings Conference Call
HUNTINGTON BEACH, Calif.–(BUSINESS WIRE)–$KRMN #earnings—Karman Space & Defense (“Karman” or “the Company”) (NYSE: KRMN), a leader... Read more.
The Arena Group to Announce Fourth Quarter 2024 Financial Results on or before April 15, 2025
NEW YORK–(BUSINESS WIRE)–The Arena Group Holdings, Inc. (NYSE American: AREN) (the “Company” or “The Arena Group”), an innovative technology... Read more.
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
NEW YORK–(BUSINESS WIRE)–$BBN–Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust... Read more.
SEI Investors Have Opportunity to Lead Solaris Energy Infrastructure, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Solaris... Read more.
Li-Cycle Reports Full Year 2024 Financial Results
Highlights Increased total revenue to $28.0 million in 2024, a 53% increase over 2023; Decreased total expenses (selling, general and administrative (“SG&A”)... Read more.
Caliber Reports Fourth Quarter and Full Year 2024 Results
2024 Platform revenue increased 1.9% compared to prior year 2024 cost reductions position Caliber for improved 2025 SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#alternativeassets–Caliber... Read more.
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing... Read more.
Accord Announces Delay in Filing Annual Financial Statements and Voluntary Application for a Management Cease Trade Order
TORONTO–(BUSINESS WIRE)–Accord Financial Corp. (“Accord” or the “Company”) (TSX: ACD) announced today that it has made a voluntary application... Read more.